Skip to main content

Peer Review reports

From: How government health insurance coverage of novel anti-cancer medicines benefited patients in China – a retrospective analysis of hospital clinical data

Original Submission
29 Oct 2020 Submitted Original manuscript
4 Sep 2020 Reviewed Reviewer Report - Bradley H Wagenaar
12 Apr 2021 Reviewed Reviewer Report - Hans Hogerzeil
24 May 2021 Reviewed Reviewer Report
26 May 2021 Reviewed Reviewer Report
13 Jun 2021 Author responded Author comments - Yifan Diao
Resubmission - Version 2
13 Jun 2021 Submitted Manuscript version 2
30 Jun 2021 Reviewed Reviewer Report
25 Jul 2021 Author responded Author comments - Yifan Diao
Resubmission - Version 3
25 Jul 2021 Submitted Manuscript version 3
26 Jul 2021 Author responded Author comments - Yifan Diao
Resubmission - Version 4
26 Jul 2021 Submitted Manuscript version 4
Publishing
30 Jul 2021 Editorially accepted
21 Aug 2021 Article published 10.1186/s12913-021-06840-3

You can find further information about peer review here.

Back to article page